Oraya Therapeutics is a biotechnology company developing non-invasive therapies for eye diseases that is headquartered in San Francisco, California and was founded in 2007 by Michael Gertner.
| Company Operating Status | Active |
|---|---|
| Full Address | 8000 Jarvis Ave., Suite 200, Newark, CA 94560, US |
| Public/Private | Private |
| Wellfound ID | oraya-therapeutics |